0 Commentaires
0 Parts
420 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Analyzing the Retinal Biosimilars Market: Key Segments, Drivers, and Regional GrowthThe retinal biosimilars market is shaped by a complex interplay of clinical needs, regulatory landscapes, and regional healthcare priorities. The retinal biosimilars market is on a strong growth trajectory, projected to reach USD 3.0 billion by 2035. A detailed analysis of its segments and regional dynamics is essential for understanding its future direction. The market is segmented...0 Commentaires 0 Parts 319 Vue 0 Aperçu
-
Analyzing the Trastuzumab Biosimilars Market: Key Segments, Drivers, and Regional GrowthThe trastuzumab biosimilars market is shaped by a complex interplay of clinical need, regulatory environments, and regional healthcare economics. The trastuzumab biosimilars market is on a strong growth trajectory, projected to reach USD 2.5 billion by 2035. A detailed analysis of its segments and regional dynamics is essential for understanding its future direction. The market is...0 Commentaires 0 Parts 311 Vue 0 Aperçu
-
Biologic Therapy Market Outlook: Biosimilars, Subcutaneous Delivery, and Global GrowthThe biologic therapy market is evolving toward biosimilar competition, subcutaneous delivery, and global expansion. These trends will shape growth and determine how biologics are used over the coming decade. Biosimilars are a major theme. As patents on blockbuster biologics expire, biosimilar competition is improving affordability and access, reshaping the competitive landscape. According to...0 Commentaires 0 Parts 120 Vue 0 Aperçu
-
Biosimilars Create New Growth Opportunities in Rheumatoid Arthritis TherapeuticsThe growing emphasis on early diagnosis and effective long-term management of autoimmune diseases is supporting demand for rheumatoid arthritis drugs. Rheumatoid arthritis is a chronic inflammatory condition that primarily affects the joints and can cause pain, swelling, stiffness, reduced mobility, and joint damage. Treatment typically involves disease-modifying antirheumatic drugs (DMARDs),...0 Commentaires 0 Parts 198 Vue 0 Aperçu
-
Biosimilars Market Expansion Accelerated by Patent Expirations and Cost PressuresThe global pharmaceutical landscape is undergoing a major shift as patent expirations for blockbuster biological drugs open pathways for high-quality alternatives. According to market research on the Biosimilars Market, rising healthcare costs are pushing national health systems and insurers to encourage lower-cost biological treatments. Biosimilar therapies provide equivalent efficacy and...0 Commentaires 0 Parts 346 Vue 0 Aperçu
-
Biosimilars Market Trends Every Pharma Strategist Should WatchBiosimilars Market to Reach USD 73.24 Billion by 2036: What Is Driving Growth Healthcare systems around the world are under pressure to deliver advanced therapies at lower cost. Biologic medicines treat cancer, autoimmune disorders, and eye diseases, but their high prices strain budgets. This is where the Biosimilars Market is making a real difference. By offering highly similar alternatives to...0 Commentaires 0 Parts 378 Vue 0 Aperçu
-
Biosimilars Market Trends Transforming the Global Biopharmaceutical Industry 2028Increasing clinical evidence is influencing the Biosimilars Market. Real-world experience, comparative studies, and post-market monitoring are contributing to a broader understanding of biosimilar performance across different patient populations. The Biosimilars Market size is expected to grow from US$ 18,435.89 million in 2021 to US$ 136,069.53 million by 2028, registering an estimated CAGR of...0 Commentaires 0 Parts 373 Vue 0 Aperçu
-
Breast Cancer Biologics: A Comprehensive Market Analysis of Trastuzumab BiosimilarsBreast cancer remains a leading cause of cancer-related deaths among women worldwide, with HER2-positive subtypes accounting for a significant portion of cases. The introduction of trastuzumab, a targeted biologic, revolutionized the treatment of this aggressive cancer. The subsequent development of breast cancer biologics in the form of trastuzumab biosimilars has expanded access to...0 Commentaires 0 Parts 466 Vue 0 Aperçu
-
Fermenters and Bioreactors Market: The Role of Biologics, Biosimilars, and Cell TherapyFermenters and Bioreactors Market: Growth, Trends, and Forecast to 2034 Overview The global Fermenters and Bioreactors Market was valued at USD 22.28 billion in 2026 and is projected to reach USD 49.17 billion by 2034, registering a CAGR of 10.4% during the forecast period. Market growth is driven by the expansion of biopharmaceutical manufacturing, rising demand for biologics and...0 Commentaires 0 Parts 819 Vue 0 Aperçu
-
Heparinoid Market Outlook: Biosimilars, Supply Security, and Global GrowthThe heparinoid market is evolving toward biosimilar competition, supply chain security, and global expansion. These trends will shape growth and determine how anticoagulation develops over the coming decade. Biosimilars are a major theme. Biosimilar LMWHs and generic heparin products are improving affordability and access. According to heparinoid market analysis, biosimilars are a key growth...0 Commentaires 0 Parts 91 Vue 0 Aperçu
-
Key Generic Injectables Market Trends: Biosimilars, Prefilled Syringes, and Supply Chain ResilienceThe generic injectables sector is undergoing a period of significant transformation, driven by patent expirations, technological breakthroughs, and evolving healthcare needs. The latest Generic Injectables Market Trends reflect a clear move towards biosimilar injectables, the increasing adoption of prefilled syringes, and a strategic focus on supply chain resilience . Trend...0 Commentaires 0 Parts 635 Vue 0 Aperçu
-
Antibodies Market Expands as Pharmaceutical R&D Investment RisesThe Antibodies Market is projected to grow from USD 256.1 billion in 2026 to USD 489.8 billion by 2036 at a 6.7% CAGR. ROCKVILLE, MD — October 6, 2026 — The Antibodies Market is projected to reach USD 489.8 billion by 2036, rising from USD 256.1 billion in 2026 at a CAGR of 6.7%, according to Fact.MR. The market was valued at approximately USD 240.0 billion in 2025 and is expected...0 Commentaires 0 Parts 928 Vue 0 Aperçu
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Global Microbial Fermentation APIs Market Growing at 1.5% CAGR Through 2032According to a new report from Intel Market Research, the global Microbial Fermentation APIs market was valued at USD 27.57 billion in 2024 and is projected to reach USD 30.56 billion by 2032, exhibiting a steady CAGR of 1.5% during the forecast period (2025–2032). This growth is driven by the increasing demand for antibiotics, amino acids, and vitamins, particularly in emerging economies...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Pharmaceutical Manufacturing Market Growth: Key Opportunities for Industry PlayersPharmaceutical Manufacturing Market to Reach USD 1,318.3 Billion by 2033 Overview According to the supplied market estimates, the global Pharmaceutical Manufacturing Market is projected to grow from USD 557.6 billion in 2025 to USD 1,318.3 billion by 2033, registering a compound annual growth rate (CAGR) of 11.8%. This growth reflects increasing pharmaceutical demand, technological...0 Commentaires 0 Parts 253 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek